Sarah Neidler,  —

Recent Posts

• Phase 3 trial is tracking use of acoramidis to block ATTR onset
• I wish my country could benefit from gains in amyloidosis treatment
• Long-term Amvuttra treatment safe, pooled trial analysis shows
• Gene therapy nex-z lowers FAP protein levels for 3 years
• YOLT-201 therapy for FAP, other forms of ATTR gets funding boost